BSE: 544365 | NSE: | Hospital & Healthcare Services |
Past 10 year’s financial track record analysis by Moneyworks4me indicates that Shanmuga Hospital Ltd is a below average quality company.
The key valuation ratios of Shanmuga Hospital Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.
The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Shanmuga Hospital Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
| Mar'22 | Mar'23 | Mar'24 | TTM | |
|---|---|---|---|---|
| ROCE % ⓘ | 127.5% | 51.7% | 33.5% | - |
| Value Creation Index ⓘ | 8.1 | 2.7 | 1.4 | - |
Growth Parameters ⓘGrowth Parameters Colour Code Guide ⓘ | ||||
| Sales ⓘ | 41.4 | 39.3 | 43 | 43 |
| Sales YoY Gr. | - | -4.9% | 9.4% | - |
| Adj EPS ⓘ | 0.7 | 4.9 | 5.4 | 3.9 |
| YoY Gr. | - | 610.1% | 9.6% | - |
| BVPS (₹) ⓘ | 0.7 | 12.2 | 17.5 | 27.7 |
| Adj Net Profit ⓘ | 6.7 | 4.8 | 5.3 | 5 |
| Cash Flow from Ops. ⓘ | 1.9 | 3 | 9.6 | - |
| Debt/CF from Ops. ⓘ | 0 | 2.6 | 0.9 | - |
CAGR Colour Code Guide ⓘ
| 9 Years | 5 Years | 3 Years | 1 Years | |||||
|---|---|---|---|---|---|---|---|---|
| Sales ⓘ | NA | NA | NA | 9.4% | ||||
| Adj EPS ⓘ | NA | NA | NA | 9.6% | ||||
| BVPSⓘ | NA | NA | NA | 43.8% | ||||
| Share Price | - | - | - | - | ||||
Performance Ratio Colour Code Guide ⓘ
| Mar'22 | Mar'23 | Mar'24 | TTM | |
|---|---|---|---|---|
| Return on Equity % ⓘ | 95.2 | 50.4 | 36.3 | 17.1 |
| Op. Profit Mgn % ⓘ | 21.9 | 18.5 | 20 | NAN |
| Net Profit Mgn % ⓘ | 16.2 | 12.1 | 12.2 | 12.2 |
| Debt to Equity ⓘ | 0 | 0.7 | 0.5 | - |
| Working Cap Days ⓘ | 0 | 79 | 91 | 0 |
| Cash Conv. Cycle ⓘ | 0 | 45 | 30 | 0 |
No data to display
Return on Equity has declined versus last 3 years average to 17.10%
Sales growth has been subdued in last 3 years 0.00%
Net Profit has been subdued in last 3 years 0.00%
Sales growth is not so good in last 4 quarters at 0.00%
| Standalone | Consolidated | |
|---|---|---|
| TTM EPS (₹) | 3.9 | - |
| TTM Sales (₹ Cr.) | 43 | - |
| BVPS (₹.) ⓘ | 27.7 | - |
| Reserves (₹ Cr.) ⓘ | 24 | - |
| P/BV ⓘ | 1.28 | - |
| PE ⓘ | 9.18 | - |
| From the Market | |
|---|---|
| 52 Week Low / High (₹) | 32.05 / 54.00 |
| All Time Low / High (₹) | 32.05 / 54.00 |
| Market Cap (₹ Cr.) | 48.3 |
| Equity (₹ Cr.) | 13.6 |
| Face Value (₹) | 10 |
| Industry PE ⓘ | 38.4 |
| Pledged * | 0.00 |
| PARTICULARS | Mar'22 | Mar'23 | Mar'24 |
|---|---|---|---|
| Sales | 41.38 | 39.34 | 43.04 |
| Operating Expenses ⓘ | 32.34 | 32.06 | 34.44 |
| Manufacturing Costs | 5.82 | 7.49 | 8.26 |
| Material Costs | 17.04 | 15.84 | 16.96 |
| Employee Cost | 3.71 | 2.99 | 3.24 |
| Other Costs ⓘ | 5.77 | 5.73 | 5.98 |
| Operating Profit ⓘ | 9.04 | 7.29 | 8.60 |
| Operating Profit Margin (%) | 21.8% | 18.5% | 20.0% |
| Other Income ⓘ | 0.09 | 0.15 | 0.35 |
| Interest ⓘ | 0.03 | 0.28 | 0.61 |
| Depreciation ⓘ | 0.13 | 0.58 | 1.30 |
| Exceptional Items ⓘ | 0 | 0 | 0 |
| Profit Before Tax ⓘ | 8.96 | 6.58 | 7.03 |
| Tax ⓘ | 2.25 | 1.82 | 1.77 |
| Profit After Tax | 6.72 | 4.76 | 5.26 |
| PAT Margin (%) | 16.2% | 12.1% | 12.2% |
| Adjusted EPS (₹) | 0.7 | 4.9 | 5.4 |
| Dividend Payout Ratio (%) | 0% | 0% | 0% |
| PARTICULARS | Mar'22 | Mar'23 | Mar'24 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
Equity and Liabilities | ||||||||||
| Shareholders Fund | 7.06 | 11.82 | 17.13 | |||||||
| Share Capital ⓘ | 0.08 | 0.08 | 9.80 | |||||||
| Reserves ⓘ | 6.98 | 11.74 | 7.34 | |||||||
| Minority Interest | 0 | 0 | 0 | |||||||
| Debt | 0 | 7.65 | 9.02 | |||||||
| Long Term Debt | 0 | 4.02 | 3.59 | |||||||
| Short Term Debt | 0 | 3.63 | 5.43 | |||||||
| Trade Payables | 0.84 | 1.49 | 5.05 | |||||||
| Others Liabilities ⓘ | 2.74 | 2.09 | 2.72 | |||||||
| Total Liabilities ⓘ | 10.65 | 23.05 | 33.92 | |||||||
Fixed Assets | ||||||||||
| Gross Block | 2.42 | 10.69 | 17.87 | |||||||
| Accumulated Depreciation | 0.14 | 0.72 | 2.02 | |||||||
| Net Fixed Assetsⓘ | 2.28 | 9.97 | 15.85 | |||||||
| CWIP ⓘ | 0 | 0 | 4.34 | |||||||
| Investmentsⓘ | 0 | 0.02 | 0.02 | |||||||
| Inventories | 0.89 | 1.58 | 1.95 | |||||||
| Trade Receivables | 4.71 | 5.86 | 6.96 | |||||||
| Cash Equivalents | 1.21 | 3.21 | 2.10 | |||||||
| Others Assetsⓘ | 1.55 | 2.40 | 2.70 | |||||||
| Total Assets ⓘ | 10.65 | 23.05 | 33.92 | |||||||
| PARTICULARS | Mar'22 | Mar'23 | Mar'24 |
|---|---|---|---|
| Cash Flow From Operating Activity ⓘ | 1.92 | 2.95 | 9.57 |
| PBT ⓘ | 8.96 | 6.58 | 7.03 |
| Adjustment ⓘ | 0.17 | 0.85 | 1.81 |
| Changes in Working Capital ⓘ | -7.12 | -2.28 | 2.44 |
| Tax Paid ⓘ | -0.09 | -2.20 | -1.72 |
| Cash Flow From Investing Activity ⓘ | -1.67 | -8.31 | -11.50 |
| Capex | -1.68 | -8.27 | -11.51 |
| Net Investments | -0.01 | -0.07 | -0.10 |
| Others ⓘ | 0.01 | 0.02 | 0.12 |
| Cash Flow From Financing Activityⓘ | -0.03 | 7.37 | 0.81 |
| Net Proceeds from Shares ⓘ | 0 | 0 | 0.05 |
| Net Proceeds from Borrowing ⓘ | 0 | 4.02 | -0.43 |
| Interest Paid ⓘ | -0.03 | -0.28 | -0.61 |
| Dividend Paid ⓘ | 0 | 0 | 0 |
| Others ⓘ | 0 | 3.63 | 1.79 |
| Net Cash Flow ⓘ | 0.21 | 2 | -1.12 |
| PARTICULARS | Mar'22 | Mar'23 | Mar'24 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Ratios | ||||||||||
| ROE (%) | 95.16 | 50.44 | 36.34 | |||||||
| ROCE (%) | 127.45 | 51.71 | 33.5 | |||||||
| Asset Turnover Ratio | 3.89 | 2.34 | 1.51 | |||||||
| PAT to CFO Conversion(x) | 0.29 | 0.62 | 1.82 | Working Capital Days | ||||||
| Receivable Days | 42 | 49 | 54 | |||||||
| Inventory Days | 8 | 11 | 15 | |||||||
| Payable Days | 18 | 27 | 70 | |||||||
Shanmuga Hospital Limited was originally incorporated as a Private Limited Company under the name 'Shanmuga Hospital Private Limited' on June 26, 2020, in accordance with the Companies Act, 2013. It received a fresh certificate of incorporation from the Registrar of Companies, Central Registration Centre. Subsequently, the company converted into a public limited company, resulting in a name change to ‘Shanmuga Hospital Limited’. This alteration was formally recorded in a new Certificate of Incorporation dated June 06, 2024, with the Corporate Identification issued by the Registrar of Companies, Central Processing Centre.
Shanmuga Hospital, a Multispecialty Hospital, was strategically established in Salem. Equipped with advanced healthcare technology, it addresses the community’s medical needs, serving patients from nearby regions. Accredited by the National Accreditation Board for Hospitals and Healthcare (NABH Accredited) and National Accreditation Board for Testing and Calibration Laboratories (NABL Accredited), its hospital is committed to high-quality healthcare services, including prevention, treatment, and rehabilitation.
Its medical facility encompasses an Oncology Unit, High Dependency Unit (HDU), Emergency Department (ED), Outpatient Consultation Services, Cardiac Care Unit (CCU), Intensive Care Unit (ICU), Neonatal Intensive Care Unit (NICU), Labour Room, Endoscopy Room, Neurosurgery Unit, and Cardiac Unit. The Diagnostic Centre features advanced laboratory and imaging technologies such as X-Ray, Ultrasound, Computed Tomography (CT) scan, Magnetic Resonance Imaging (MRI), and modular operational theatres. Providing extensive inpatient and outpatient care across various Medical and Surgical specialties, its facility is well-equipped to meet diverse healthcare needs.
The company’s success comes from providing quality healthcare at affordable rates, appreciations to its skilled medical professionals who connect personally with patients. It has built a reputation for delivering top-notch medical services at competitive prices. As a growing organization, its goal is to solidify its position as a leading healthcare provider. It is committed to continuous improvement in its facilities, aiming for a higher standard of care and quality.
Business area of the company
The company is equipped with advanced healthcare technology, it addresses the community’s medical needs, serving patients from nearby regions.
History and milestones
MoneyWorks4Me rating and ranking of funds for SIP is available to subscribers only. Moneyworks4Me is not a rating and ranking agency, however it is required that users have a way of selecting funds and building a Portfolio. The method used by it are described below to enable users to understand the logic behind the rating and ranking Subscriber will find more details on this in the various content made available from time to time. In case you need more please write to besafe@moneyworks4Me.com
MoneyWorks4Me rates and ranks mutual funds based on the following data-driven system:
Funds ranking in screeners: Performance Consistency and Quality are two parameters used for ranking funds for SIP. The ranking as follows GG, GO, GR, OG, OO, OR, RG, RO and RR.
With the same color-coded funds, the one with the higher Average 3-year rolling returns (over 5 to 10 years), the number that appears in the Performance tag, ranks higher.
Here is the summary:
The third tag Upside Potential is not relevant for SIP. It is relevant for lumpsum investments in Mutual Funds.
Make an informed decision for Stocks
Invest using an intelligent system with powerful data-driven tools that help you identify opportunities and make informed buy-hold-sell decisions
Buy quality Stocks when they are available at reasonable prices and supported by an upward price trend and Sell when they are Overvalued using the Decizen Rating System. Covers 3500+ stocks
100% Secure Process
Account Discovery
- OTP from CAMS
Account Linking for Stocks & MF
- One OTP per link Eg. NSDL, CDSL, CAMS, KFin etc.
One Click Upload for your Current Portfolio and Future Transactions!
Don't miss out! First 10 users today get it FREE
With this 4 hrs Masterclass, you’ll be able to:
Download APP
